TrialClinical pharmacokinetics2008

Determinants of steady-state torasemide pharmacokinetics: impact of pharmacogenetic factors, gender and angiotensin II receptor blockers.

Dierk Werner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.